Deloitte Canada and NovaBay back stablecoins as Stablecorp’s QCAD gains traction

NovaBay Pharmaceuticals said it will exit biotech and rebrand as Stablecoin Development Corporation (SDEV) effective April 3, 2026, after which its stock rose 18%. The company said it has raised $134 million from investors including Tether and Framework Ventures and holds over 2.06 billion SKY tokens to pursue returns via blockchain protocols, while Deloitte Canada separately partnered with Stablecorp to build financial systems using QCAD.